Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celcuity Inc.CELC · Entity 3991 | Chief Financial Officer | August 14, 2026 | August 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celcuity Inc.
Report date August 14, 2026 · Filed August 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,808 |
Reported balance
After 2026-08-14 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-14 · Grant · Acquired 16,000 · Balance 37,808 F1: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date. F2: Includes 2,948 shares acquired pursuant to the Celcuity Inc. (the "Company") employee stock purchase plan. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 10,000 |
Reported balance
After 2026-08-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-14 · Grant · Acquired 10,000 · Balance 10,000 F3: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date.
F2: Includes 2,948 shares acquired pursuant to the Celcuity Inc. (the "Company") employee stock purchase plan.
F3: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC | Celcuity Inc. CELC · Entity 3991 | GrantPerformance Stock Units · Derivative | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001716043-26-000002 · form4-08182026_080833.xml · derivative · entry 2 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires not disclosed F3 · derivative.exercise_price: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds. F3 · derivative.exercise_date: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds. F3 · derivative.expiration_date: Each performance stock unit represents a contingent right to receive one share of the Company's common stock. The performance stock units vest upon the Company's common stock achieving certain specified trailing average per share price thresholds. Read SEC document |
| August 14, 2026 Filed Aug 18, 2026 20:17 UTC | Celcuity Inc. CELC · Entity 3991 | GrantCommon Stock | 16,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001716043-26-000002 · form4-08182026_080833.xml · nonDerivative · entry 1 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,808 F1 · shares: 25% of the total number of restricted stock units vests on the first day of the month following each of the first, second, third and fourth anniversaries of the grant date. F2 · balance_after: Includes 2,948 shares acquired pursuant to the Celcuity Inc. (the "Company") employee stock purchase plan. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 20:30 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $51.57 | $0.00 |
DisclosureSEC source: 0001415889-25-022448 · form4-08202025_040805.xml · derivative · entry 1 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2035-08-18 F1 · derivative.exercise_date: 20,000 shares vest on 8/18/2026; the remaining 60,000 shares vest 1/36th per month thereafter. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 21:18 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 11,328 | $0.00 Strike: $13.13 | $0.00 |
DisclosureSEC source: 0001415889-25-000752 · form4-01062025_090143.xml · derivative · entry 2 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,328 Underlying: Common Stock · 11,328 shares Expires 2035-01-02 F2 · derivative.exercise_date: Stock options vest and become exercisable in 12 equal installments on the last day of each month following the grant date, beginning on January 31, 2025 and ending on December 31, 2025. Read SEC document |
| August 20, 2024 Filed Aug 22, 2024 20:22 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $17.04 | $0.00 |
DisclosureSEC source: 0001062993-24-015558 · form4.xml · derivative · entry 18 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-08-20 F12 · derivative.exercise_date: 20,000 shares vest on 8/20/25; the remaining 60,000 shares vest 1/36th per month thereafter. Read SEC document |
| August 20, 2024 Filed Aug 26, 2024 21:40 UTC Amendment | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $17.04 | $0.00 |
DisclosureSEC source: 0001062993-24-015670 · form4a.xml · derivative · entry 1 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2034-08-20 F1 · derivative.exercise_date: 20,000 shares vest on 8/20/25; the remaining 60,000 shares vest 1/36th per month thereafter. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 22:25 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 5,530 | $0.00 Strike: $15.03 | $0.00 |
DisclosureSEC source: 0001062993-24-003329 · form4.xml · derivative · entry 17 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,530 Underlying: Common Stock · 5,530 shares Expires 2034-02-13 F12 · derivative.exercise_date: These shares vest in equal amounts on the first day of each month over twelve (12) months, beginning March 1, 2024 Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 20:45 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $9.89 | $0.00 |
DisclosureSEC source: 0001062993-23-017211 · form4.xml · derivative · entry 16 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-08-25 F12 · derivative.exercise_date: 15,000 shares vest on 8/25/24; the remaining 45,000 shares vest 1/36th per month thereafter. Read SEC document |
| August 25, 2023 Filed Aug 29, 2023 20:45 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 21,250 | $0.00 Strike: $9.89 | $0.00 |
DisclosureSEC source: 0001062993-23-017211 · form4.xml · derivative · entry 15 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,250 Underlying: Common Stock · 21,250 shares Expires 2033-08-25 F11 · derivative.exercise_date: These shares vest in equal amounts on the last day of each month over seventeen (17) months, beginning August 31, 2023. Read SEC document |
| February 16, 2023 Filed Feb 21, 2023 21:27 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 5,069 | $0.00 Strike: $11.55 | $0.00 |
DisclosureSEC source: 0001062993-23-004238 · form4.xml · derivative · entry 14 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,069 Underlying: Common Stock · 5,069 shares Expires 2033-02-16 F12 · derivative.exercise_date: These shares vest in equal amounts over twelve (12) months, beginning February 16, 2023. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (Right to Buy) · Derivative | 31,930 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 22 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,930 Underlying: Common Stock · 31,930 shares Expires 2032-05-17 F13 · derivative.exercise_date: These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 821 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 21 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821 Underlying: Common Stock · 821 shares Expires 2031-10-27 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F12 · derivative.exercise_date: 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 821 | Not disclosed Strike: $17.19 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 20 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 821 shares Expires 2031-10-27 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F12 · derivative.exercise_date: 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 19 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-08-11 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $20.04 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 18 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2031-08-11 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F11 · derivative.exercise_date: 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,806 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 17 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 Underlying: Common Stock · 3,806 shares Expires 2031-04-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 3,806 | Not disclosed Strike: $27.94 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 16 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,806 shares Expires 2031-04-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F10 · derivative.exercise_date: 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,204 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 15 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Stock · 1,204 shares Expires 2031-03-18 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 1,204 | Not disclosed Strike: $15.92 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 14 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,204 shares Expires 2031-03-18 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F9 · derivative.exercise_date: 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,301 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 13 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 Underlying: Common Stock · 1,301 shares Expires 2031-02-02 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 1,301 | Not disclosed Strike: $14.84 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 12 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,301 shares Expires 2031-02-02 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F8 · derivative.exercise_date: 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,122 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 11 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122 Underlying: Common Stock · 1,122 shares Expires 2030-12-28 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 1,122 | Not disclosed Strike: $10.35 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 10 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,122 shares Expires 2030-12-28 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F7 · derivative.exercise_date: 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 8 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-08-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F5 · derivative.exercise_date: 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $19.72 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 7 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2029-08-12 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F5 · derivative.exercise_date: 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 932 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 6 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 Underlying: Common Stock · 932 shares Expires 2028-10-17 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 932 | Not disclosed Strike: $25.77 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 5 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 932 shares Expires 2028-10-17 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F4 · derivative.exercise_date: 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $5.50 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 4 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2028-07-05 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| May 17, 2022 Filed May 20, 2022 00:39 UTC | Celcuity Inc. CELC · Entity 3991 | Disposition to issuerStock Option (right to buy) · Derivative | 3,000 | Not disclosed Strike: $23.48 | Not disclosed |
DisclosureSEC source: 0001437749-22-013128 · rdgdoc.xml · derivative · entry 3 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,000 shares Expires 2028-07-05 F14 · price: The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option. F3 · derivative.exercise_date: 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| October 27, 2021 Filed Oct 29, 2021 20:47 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 821 | $0.00 Strike: $17.19 | $0.00 |
DisclosureSEC source: 0000914190-21-000383 · edgar.xml · derivative · entry 12 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 821 Underlying: Common Stock · 821 shares Expires 2031-10-27 F11 · derivative.exercise_date: 205 shares vest on 10/27/22; the remaining 616 shares vest 1/36th per month thereafter. Read SEC document |
| August 11, 2021 Filed Aug 13, 2021 20:01 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $20.04 | $0.00 |
DisclosureSEC source: 0000914190-21-000257 · edgar.xml · derivative · entry 11 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-08-11 F11 · derivative.exercise_date: 3,750 shares vest on 8/11/22; the remaining 11,250 shares vest 1/36th per month thereafter. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 21:47 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,806 | $0.00 Strike: $27.94 | $0.00 |
DisclosureSEC source: 0000914190-21-000119 · edgar.xml · derivative · entry 10 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,806 Underlying: Common Stock · 3,806 shares Expires 2031-04-12 F9 · derivative.exercise_date: 952 shares vest on 4/12/22; the remaining 2,854 shares vest 1/36th per month thereafter. Read SEC document |
| March 18, 2021 Filed Mar 22, 2021 20:25 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,204 | $0.00 Strike: $15.92 | $0.00 |
DisclosureSEC source: 0000914190-21-000088 · edgar.xml · derivative · entry 9 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,204 Underlying: Common Stock · 1,204 shares Expires 2031-03-18 F8 · derivative.exercise_date: 301 shares vest on 3/18/22; the remaining 903 shares vest 1/36th per month thereafter. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 22:13 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,301 | $0.00 Strike: $14.84 | $0.00 |
DisclosureSEC source: 0000914190-21-000031 · edgar.xml · derivative · entry 8 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,301 Underlying: Common Stock · 1,301 shares Expires 2031-02-02 F7 · derivative.exercise_date: 325 shares vest on 2/2/22; the remaining 976 shares vest 1/36th per month thereafter. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 22:39 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 1,122 | $0.00 Strike: $10.35 | $0.00 |
DisclosureSEC source: 0000914190-20-000469 · edgar.xml · derivative · entry 7 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122 Underlying: Common Stock · 1,122 shares Expires 2030-12-28 F7 · derivative.exercise_date: 280 shares vest on 12/29/21; the remaining 842 shares vest 1/36th per month thereafter. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:22 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $5.90 | $0.00 |
DisclosureSEC source: 0000914190-20-000298 · edgar.xml · derivative · entry 6 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-08-12 F6 · derivative.exercise_date: 2,500 shares vest on 8/12/21; the remaining 7,500 shares vest 1/36th per month thereafter. Read SEC document |
| August 12, 2019 Filed Aug 14, 2019 20:09 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0000914190-19-000299 · edgar.xml · derivative · entry 5 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2029-08-12 F5 · derivative.exercise_date: 750 shares vest on 8/12/20; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
| October 17, 2018 Filed Oct 19, 2018 21:21 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 932 | $0.00 Strike: $25.77 | $0.00 |
DisclosureSEC source: 0001144204-18-054602 · tv505125_4.xml · derivative · entry 3 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 932 Underlying: Common Stock · 932 shares Expires 2028-10-17 F3 · derivative.exercise_date: 233 shares vest on 10/17/19; the remaining 699 shares vest 1/36th per month thereafter. Read SEC document |
| July 05, 2018 Filed Jul 9, 2018 20:06 UTC | Celcuity Inc. CELC · Entity 3991 | GrantStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $23.48 | $0.00 |
DisclosureSEC source: 0000914190-18-000275 · edgar.xml · derivative · entry 2 Hahne Vicky · CIK 0001716043 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 3,000 shares Expires 2028-07-05 F2 · derivative.exercise_date: 750 shares vest on 7/5/19; the remaining 2,250 shares vest 1/36th per month thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.